urological agents

Preferred Label : urological agents;

MeSH definition : Drugs used in the treatment of urogenital conditions and diseases such as URINARY INCONTINENCE; PROSTATIC HYPERPLASIA; and ERECTILE DYSFUNCTION.; Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS.;

MeSH synonym : agents, urological; urologic agents; agents, urologic;

Is substance : O;

action pharmacologique : O;

Détails

Origin ID

D064804;

UMLS CUI

C2064919;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Metaterm(s)
- urology [CISMeF Metaterm]
Record concept(s)
- urological agents [MeSH concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- Sildenafil Citrate [MeSH Descriptor]
- Solifenacin Succinate [MeSH Descriptor]
- Tadalafil [MeSH Descriptor]
- Tamsulosin [MeSH Descriptor]
- Terazosin [MeSH Supplementary Concept]
- Tolterodine Tartrate [MeSH Descriptor]
- Vardenafil Dihydrochloride [MeSH Descriptor]
- alfuzosin [MeSH Supplementary Concept]
- alprostadil [MeSH Descriptor]
- darifenacin [MeSH Supplementary Concept]
- emepronium [MeSH Descriptor]
- emepronium carrageenate [MeSH Supplementary Concept]
- fesoterodine [MeSH Supplementary Concept]
- fexapotide triflutate [MeSH Supplementary Concept]
- finasteride [MeSH Descriptor]
- flavoxate [MeSH Descriptor]
- mepartricin [MeSH Descriptor]
- mirabegron [MeSH Supplementary Concept]
- oxybutynin [MeSH Supplementary Concept]
- paljung-san [MeSH Supplementary Concept]
- papaverine [MeSH Descriptor]
- propiverine [MeSH Supplementary Concept]
- saw palmetto extract [MeSH Supplementary Concept]
- silodosin [MeSH Supplementary Concept]
- trospium chloride [MeSH Supplementary Concept]
- yohimbine [MeSH Descriptor]

Position du mot-clé dans l'(les) arborescence(s) :

Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients